| Autor: |
Heather N. Bader, Daniel Paull, Carina Seah, Tom Rusielewicz, Migle Staniskyte, Rachel Yehuda, Mitali Chattopadhyay, Michael S. Breen, Barry McCarthy, Kristen J. Brennand, Changxin Xu, Linda M. Bierer, Nyscf Global Array Team, Janine D. Flory, Christopher J. Hunter, Frank Desarnaud, Iouri Makotkine, Scott Noggle |
| Rok vydání: |
2021 |
| Předmět: |
|
| DOI: |
10.1101/2021.03.01.433391 |
| Popis: |
Post-traumatic stress disorder (PTSD) results from severe trauma exposure, but the extent to which genetic and epigenetic risk factors impact individual clinical outcomes is unknown. We assessed the impact of genomic differences following glucocorticoid administration by examining the transcriptional profile of human induced pluripotent stem cell (hiPSC)-derived glutamatergic neurons and live cultured peripheral blood mononuclear cells from combat veterans with PTSD (n=5) and without PTSD (n=5). This parallel examination in baseline and glucocorticoid-treated conditions resolves cell-type specific and diagnosis-dependent elements of stress response, and permits discrimination of gene expression signals associated with PTSD risk from those induced by stress. Computational analyses revealed neuron-specific glucocorticoid-response expression patterns that were enriched for transcriptomic patterns observed in clinical PTSD samples. PTSD-specific signatures, albeit underpowered, accurately stratify veterans with PTSD relative to combat-exposed controls. Overall, in vitro PTSD and glucocorticoid response signatures in blood and brain cells represent exciting new platforms with which to test the genetic and epigenetic mechanisms underlying PTSD, identify biomarkers of PTSD risk and onset, and conduct drug-screening to identify novel therapeutics to prevent or ameliorate clinical phenotypes. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
